SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/92AEF3805F438A95DDC66777E372EC09476B1207AFBEE2A5376746A59866A0038EF22D1AFB67B95AAD67500E8FB442BF>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/92AEF3805F438A95DDC66777E372EC09476B1207AFBEE2A5376746A59866A0038EF22D1AFB67B95AAD67500E8FB442BF
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/92AEF3805F438A95DDC66777E372EC09476B1207AFBEE2A5376746A59866A0038EF22D1AFB67B95AAD67500E8FB442BF
http://www.w3.org/2000/01/rdf-schema#comment
"Targeting TJP1 attenuates cell-cell aggregation and modulates chemosensitivity against doxorubicin in leiomyosarcoma."
xsd:string
http://purl.uniprot.org/uniprot/#_D41251F32D7118595F655D7A8749F2D8E8EFD24C71D08851976539E74CDBB91A05D706F09477D023CC63BBBDC50FA25E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/92AEF3805F438A95DDC66777E372EC09476B1207AFBEE2A5376746A59866A0038EF22D1AFB67B95AAD67500E8FB442BF
http://purl.uniprot.org/uniprot/G5E9E7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/92AEF3805F438A95DDC66777E372EC09476B1207AFBEE2A5376746A59866A0038EF22D1AFB67B95AAD67500E8FB442BF
http://purl.uniprot.org/uniprot/#_G5E9E7-mappedCitation-32318747
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/92AEF3805F438A95DDC66777E372EC09476B1207AFBEE2A5376746A59866A0038EF22D1AFB67B95AAD67500E8FB442BF